Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baxter International (BAX)
NYSE:BAX
Baxter International (BAX) Stock Price & Analysis
1,243 Followers
BAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$30.55 - $49.12
Previous Close$35.25
Volume3.58M
Average Volume (3M)3.82M
Market Cap
$17.96B
Enterprise Value$29.07B
Total Cash (Recent Filing)$3.19B
Total Debt (Recent Filing)$14.24B
Price to Earnings (P/E)-76.5
Beta0.80
Next Earnings
Jul 25, 2024EPS Estimate
$0.66Next Dividend Ex-Date
May 31, 2024Dividend Yield3.29%
Share Statistics
EPS (TTM)-0.46
Shares Outstanding509,580,190
10 Day Avg. Volume5,159,932
30 Day Avg. Volume3,817,559
Standard Deviation0.08
R-Squared0.21
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-4.28
Price to Sales (P/S)4.78
Price to Cash Flow (P/CF)8.50
P/FCF Ratio10.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.96
Enterprise Value/Gross Profit5.84
Enterprise Value/Ebitda33.26
Forecast
1Y Price Target
$44.25Price Target Upside25.53% Upside
Rating ConsensusHold
Number of Analyst Covering8
Baxter International News
PremiumCompany Announcements
Baxter International’s Governance and Executive Decisions at 2024 Meeting
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceThe company beat Stifel/Consensus revenue and EPS expectations.
Product ApprovalFDA cleared BAX’s Novum IQ large volume pump (LVP), which was excluded from BAX’s 2024 guidance, indicating potential unanticipated revenue.
Strategic DivestitureAnalyst recommends a sale of KidneyCo as it likely offers better value upfront for BAX shareholders compared to a spin-off.
Bears Say
Corporate RestructuringThe Kidney Care business, set to be spun-off, was a significant outperformance driver, suggesting a possibly more-dilutive RemainCo impact once separated.
Operational PerformanceHill-Rom Healthcare Systems & Technologies integration struggles continued with the business declining 9% in the quarter.
Product CompetitionAlaris was approved approximately 7 months ahead of Novum IQ, possibly reducing the anticipated upside for BAX.
---
Ownership Overview
5.53% Insiders
39.25% Mutual Funds
50.77% Other Institutional Investors
4.45% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BAX FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest stock price was $30.55 and its highest was $49.12 in the past 12 months.
What is Baxter International’s market cap?
Currently, no data Available
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is Jul 25, 2024 which is in 68 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on May 02, 2024. The company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.607 by $0.043.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 3.29%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is $0.66.
How many shares outstanding does Baxter International have?
Baxter International has 509,580,200 shares outstanding.
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of $0.65 in its last earnings report, beating expectations of $0.607. Following the earnings report the stock price went down -8.503%.
Which hedge fund is a major shareholder of Baxter International?
Among the largest hedge funds holding Baxter International’s share is Dodge & Cox. It holds Baxter International’s shares valued at 1B.
---
Baxter International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$44.25 (25.53% Upside)
$44.25 (25.53% Upside)
Blogger Sentiment
Bullish
BAX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 896.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.16%
12-Months-Change
Fundamentals
Return on Equity
-0.54%
Trailing 12-Months
Asset Growth
-1.78%
Trailing 12-Months
Company Description
Baxter International
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
---
BAX Company Deck
---
BAX Earnings Call
Q1 2024
0:00 / 0:00
---
BAX Net sales Breakdown
33.83% Medical Products and Therapies
30.06% Kidney Care
20.34% Healthcare Systems and Technologies
15.18% Pharmaceuticals
0.59% Other
---
BAX Stock 12 Month Forecast
Average Price Target
$44.25
▲(25.53% Upside)
Technical Analysis
Best Analysts Covering BAX
1 Year
1 Year Success Rate
7/20 ratings generated profit
1 Year Average Return
-5.75%
assigned a buy rating 2 months ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 35.00% of your transactions generating a profit, with an average return of -5.75% per trade.
---